Home • SuperSonic Imagine • Supervisory Board

Supervisory Board


MB portrait1



Michael Brock

Michael Brock, Chairman of the Supervisory Board of SuperSonic Imagine, appointed in November 2016, was the CEO of the Danish company BK Medical, a leader in ultrasound technology in the area of urology and surgery.

Mr. Michael Brock had been Managing Director and President of B-K Medical A/S at Analogic Corporation and also served as its Chief Executive Officer. Previously, he served as President of GN Otometrics, a subsidiary of GN Resound A/S. In 1979, he joined Bruel & Kjaer, the original parent company of B-K Medical, where he headed the Sales & Marketing Group covering the entire Sound & Vibration segment. He  was subsequently promoted to President of the Sound & Vibration Division, and was later appointed President of the Environmental and Transducer Divisions as well. In 1997, Mr. Brock joined the GN Group as President of Madsen Electronics A/S, a smaller company within the Audiologic Measuring Equipment business. Under his aegis, the company developed into the world's leading manufacturer of diagnostic hearing and balance instrumentation and software. In 2001, Madsen Electronics was renamed GN Otometrics A/S, one of GN's four core business areas today.

Mr. Brock holds a Master of Science degree in Electronic Engineering, Acoustics, from the Technical University of Denmark.









Philippe Boucheron

Philippe Boucheron is the co-founder Bioam Funds. He sits on the board of several Biotech of Medtech companies.

Between 1993 and 1996, Philippe Boucheron worked as an associate at BioCapital LP, one of the largest Canadian venture capital funds focusing on healthcare.
From 1997 to 2000, he directed the mid-caps equity research team at ING Barings Ferri, Paris. Here, he spent a significant part of his time following French and European listed biotech companies. In 2000, he co-founded the Bioam Funds dedicated to early-stage life science investments and became Investment Manager, then in 2004 Managing Partner.
After the merger of Bioam with CDC entreprises in July 2010, Philippe Boucheron joined the CDC Entreprises life sciences' team as Investment Manager.
In 2013, CDC Entreprises, FSI and Oséo merged to create Bpifrance. Since then, he is deputy chief of the Life Investments BU and sits on Bpifrance Investissement's Investment Committee. Philippe Boucheron also sits on the boards of Ademtech, Integragen, SSI, Advicenne, ART, GamaMabs and CorWave. Philippe Boucheron holds an engineering degree in Biochemical Engineering and Microbial genetics from the Institut National des Sciences Appliquées in Toulouse, a MSc in Biochemical Engineering from the Ecole Polytechnique.


thierry chignon



Thierry Chignon

 Thierry Chignon has over 25 years of professional experience in the fields of quality assurance, regulatory affairs, the conduct of clinical trials and marketing of medical devices, including nearly ten years of experience as a Pharmacist at within Pasteur Mérieux Connaught (now Sanofi Pasteur).

As director of Quintiles Consulting in Europe, he defined and participated in the implementation of business development strategies for innovative products in Europe. Thierry has worked for 5 years as Expert of the EU Commission to draft "Guidelines and Regulations for medical devices" and presided over the standardization work within CEN and ISO. Between 2006 and 2013, Thierry was involved in creating the first European investment fund dedicated to the Medical Technology sector (with a size of 80M €).
He holds a Pharmacist degree and a PhD in Pharmacy, Thierry also holds a Master in Health Management and Policy from the IEP Paris and the Executive MBA from HEC Paris.

Thierry joined Mérieux Développement in May 2014.



Sabine Lochmann

Sabine Lochmann

Managing Director, BPI Group.
Sabine Lochmann has a dual French-American legal background. She is a graduate of Paris 1 Panthéon-Sorbonne and the University of Davis, California (LLB in business law). Additionally, Sabine completed an Executive Leadership Program in South Africa (University of Cape Town).

Sabine began her career as a lawyer focused in the services sector, working with Jacobs Serete and JC Decaux before taking direction of the legal department of Johnson & Johnson France in 1998.  
In 2008, she accepted a new career challenge in, assuming the role of Marketing Director at Johnson & Johnson, followed by General Director in charge of Market Access, and then General Director of government and strategic affairs in 2010.
She is also actively involved in a number of professional organizations, including “Juristes d’Entreprise” (AFJE), of which she served as President from 2001 to 2005. She also served as Vice President of the European Confederation of business lawyers (ECLA) from 2003 to 2006.
Sabine has also founded several think-tanks, including “Avenir Femmes Santé” in 2011, dedicated to women’s health issues, and the “Ateliers de la Convergence” in January 2012, bringing together business leaders, social partners, and HR specialists on the subject of competitiveness, employment, and legal issues. Since April 2013, she had joined Supersonic Imagine as Independent board Director.

Sabine joined BPI group as Managing Director in 2014, and focuses on commercial development in France and internationally.




Alexia Perouse

Alexia Perouse has a mix Neurosciences & Management of Enterprise background and joined the venture capital field in 1999. Partner at Omnes Capital, she invests in Life science and  has developed the Medical Device portfolio.

Alexia Perouse has particularly followed the companies Biolipox (merged with Orexo in 2007) and Mutabilis (sold to Pharma Omnium International in 2009).
She has invested in Fovea Pharmaceuticals (sold to Sanofi Aventis in 2009). In addition of her investment in SuperSonic Imagine since the Serie A, she has developed the Medtech portfolio through numerous investments in Cellnovo, CircuLite, Eos Imaging, EyeTechCare, SpineGuard and Stentys (IPO in 2010). She currently sits at 6 boards.

Before joining the venture capital within Sofinnova Partners and then  CAPE in 2005, Alexia Perouse has carried out missions of consulting & business development at Parteurop Développement for biotech start-ups. She started her career as an analyst at Chiron Vaccines.



Guy Frija

Recognised expert in medical imaging, Guy Frija is professor emeritus of radiology and consultant at the imaging department of Paris Georges Pompidou European Hospital (GPEH), where he has previously served as chairman. He is also a part-time professor of radiology at the faculty of health sciences of McMaster University in Ontario, Canada.
Prof. Frija is a recognised expert in thoracic imaging and contrast products and has also helped to introduce information technologies to daily radiological practice. Recently, his main area of research has been radiation protection and he has cooperated in the establishment of guidelines and protocols in France.
He is a member of the scientific committee of the Institute for Radiological Protection and Nuclear Safety, co-chair of the imaging section of MEDICEN, a French business cluster specialising in biomedical engineering, and chair of the steering committee of EuroSafe Imaging.
Prof. Frija has served in many leadership roles, notably as president of the European Society of Radiology from 2013 to 2014. He has also presided over the French Society of Radiology for 12 years, turning it into the most important scientific society in France, and the International Society for Strategic Studies in Radiology in 2007.
He was advisor to the French Ministry of Health for the deployment of PACS in the country and is a former IAEA consultant.
Prof. Frija is Doctor Honoris Causa of the University of Montreal, and an honorary fellow of several radiological societies. He was appointed Knight of the French Order of the Legion of Honour in 2001.
He has published more than 175 papers in peer-reviewed journals and co-written 30 books.

Be always one step ahead!
Subscribe to our newsletter and be informed first on new products or events.